Market Closed -
Other stock markets
|
After market 04:00:00 pm | |||
216 EUR | -1.82% | 221 | +2.31% |
May. 07 | Transcript : Equifax Inc. Presents at Barclays Americas Select Franchise Conference 2024, May-07-2024 09:45 AM | |
May. 06 | Equifax Announces Executive Changes | CI |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 41.31 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Professional Information Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.17% | 28.96B | - | ||
-1.87% | 134B | A- | ||
+18.52% | 75.32B | B- | ||
+15.15% | 37.77B | B+ | ||
-14.70% | 37.29B | B+ | ||
-8.61% | 16.54B | B+ | ||
+9.55% | 10.49B | B | ||
-10.94% | 4.48B | B | ||
-32.61% | 4.12B | B | ||
+21.43% | 2.35B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EFX Stock
- EFX Stock
- Ratings Equifax Inc.